Brief: Kilpest India's TRURAPID COVID-19 AG Test Approved By Indian Council Of Medical Research
03/02/2022 08:00
Feb 3 (Reuters) - Kilpest India Ltd KILP.BO :
* TRURAPID COVID-19 AG TEST APPROVED BY INDIAN COUNCIL OF
MEDICAL
RESEARCH ON FEB 2
Source text for Eikon: ID:nBSE6179H5
Further company coverage: KILP.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 3B Blackbio DX
See all newsBrief: 3B Blackbio DX Gets Tax Order For Demand Of 44.6 Million Rupees
Brief: 3B Blackbio DX Gets Order Worth 13.7 Million Rupees
Brief: 3B Blackbio Dx Gets Export Order Worth $192,800
Brief: Kilpest India Says National Company Law Tribunal Approved Scheme Of Amalgamation Between 3B Blackbio Biotech India, Kilpest India
Brief: Kilpest India Final Dividend 2.5 Rupees Per Share